Benitec Biopharma (BNTC) Times Interest Earned (2020 - 2025)
Benitec Biopharma (BNTC) posted Times Interest Earned of -$0.9 for Q4 2025, down 159792.44% sequentially from -$0.0 in Q3 2025, and down 86823.06% YoY from N/an in Q4 2024.
Benitec Biopharma (BNTC) Times Interest Earned (2020 - 2025) Analysis & Trends
Benitec Biopharma has reported Times Interest Earned for 6 years, with the latest figure at -$0.9 in Q4 2025.
- Quarterly Times Interest Earned fell 86823.06% year-over-year to -$0.9 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.26 (down 129045.89% YoY) and the FY2025 annual result came in at -$0.01, up 43.7% from the prior year.
- Times Interest Earned slipped to -$0.9 in Q4 2025 per BNTC's latest filing, from -$0.0 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.0 in Q3 2025 and troughed at -$474.12 in Q1 2021.
- A 5-year average of -$32.95 and a median of -$4.31 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned surged 99.99% in 2024, then tumbled 1166407.89% in 2025.
- Over 5 years, Times Interest Earned stood at -$31.81 in 2021, then jumped by 75.74% to -$7.72 in 2022, then soared by 92.04% to -$0.61 in 2023, then soared by 99.83% to -$0.0 in 2024, then sank by 86823.06% to -$0.9 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$0.9, -$0.0, and -$27.62 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | -0.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.90 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -27.62 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | -0.61 |
| Sep 30, 2023 | -17.18 |
| Jun 30, 2023 | -0.38 |
| Mar 31, 2023 | -2.89 |
| Dec 31, 2022 | -7.72 |
| Sep 30, 2022 | -5.73 |
| Jun 30, 2022 | -24.17 |
| Mar 31, 2022 | -24.71 |
| Dec 31, 2021 | -31.81 |
| Sep 30, 2021 | -21.15 |
| Jun 30, 2021 | -20.08 |
| Mar 31, 2021 | -474.13 |